BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36949364)

  • 1. Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells.
    Chen CL; Hernandez JC; Uthaya Kumar DB; Machida T; Tahara SM; El-Khoueiry A; Li M; Punj V; Swaminathan SK; Kirtane A; Chen Y; Panyam J; Machida K
    Adv Sci (Weinh); 2023 May; 10(14):e2206812. PubMed ID: 36949364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
    Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
    J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.
    Huang G; Jiang H; Lin Y; Xia W; Luo Y; Wu Y; Cai W; Zhou X; Jiang X
    J Exp Clin Cancer Res; 2018 Jun; 37(1):121. PubMed ID: 29925408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
    Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
    Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
    Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
    Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma.
    Wang S; Liu J; Wu H; Jiang A; Zhao K; Yan K; Wu W; Han H; Zhang Y; Yang W
    Chin J Cancer Res; 2021 Dec; 33(6):694-707. PubMed ID: 35125813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.
    Schech AJ; Shah P; Yu S; Sabnis GJ; Goloubeva O; Rosenblatt P; Kazi A; Chumsri S; Brodie A
    Breast Cancer Res Treat; 2015 Aug; 152(3):499-508. PubMed ID: 26133921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
    Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
    Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
    Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
    Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.
    Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
    J Exp Clin Cancer Res; 2018 May; 37(1):105. PubMed ID: 29764463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL11 promotes self-renewal and tumorigenicity of α2δ1
    Zhang Y; Zhao W; Li S; Lv M; Yang X; Li M; Zhang Z
    Cancer Lett; 2019 May; 449():163-171. PubMed ID: 30771435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.
    Fu X; Zhu X; Qin F; Zhang Y; Lin J; Ding Y; Yang Z; Shang Y; Wang L; Zhang Q; Gao Q
    Mol Cancer; 2018 Mar; 17(1):73. PubMed ID: 29540185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.
    Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G
    J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
    Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
    Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer.
    Moro M; Bertolini G; Pastorino U; Roz L; Sozzi G
    J Thorac Oncol; 2015 Jul; 10(7):1027-36. PubMed ID: 26020124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression.
    Chen ZZ; Huang L; Wu YH; Zhai WJ; Zhu PP; Gao YF
    Nat Commun; 2016 Aug; 7():12598. PubMed ID: 27553854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.